Bicycle Therapeutics (BCYC) Prepaid Assets (2018 - 2026)
Bicycle Therapeutics (BCYC) reported Prepaid Assets of $18.7 million for Q1 2026, up 11.98% on a YoY basis from $16.7 million in Q1 2025, and down 2.28% quarter-over-quarter from $19.2 million in Q4 2025.
Bicycle Therapeutics (BCYC) Prepaid Assets (2018 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Prepaid Assets for 9 years, with the latest figure at $18.7 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 11.98% year-over-year to $18.7 million; the trailing twelve-month figure through Mar 2026 stood at $18.7 million (up 11.98% YoY), and the FY2025 full-year result was $19.2 million, up 42.8% from the prior year.
- Prepaid Assets for Q1 2026 stood at $18.7 million, down from $19.2 million in the prior quarter.
- The five-year high for Prepaid Assets was $23.2 million in Q3 2025, with the low at $8.4 million in Q3 2022.
- Historically, Prepaid Assets has averaged $14.9 million across 5 years, with a median of $13.7 million in 2023.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 101.7% — and 2025, when it fell 15.9%.
- Bicycle Therapeutics' Prepaid Assets stood at $9.0 million in 2022, then grew by 26.42% to $11.4 million in 2023, then gained by 17.76% to $13.4 million in 2024, then soared by 42.8% to $19.2 million in 2025, then declined by 2.28% to $18.7 million in 2026.
- The last three Prepaid Assets figures came in at $18.7 million (Q1 2026), $19.2 million (Q4 2025), and $23.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.74 Mn |
| Dec 31, 2025 | 19.18 Mn |
| Sep 30, 2025 | 23.23 Mn |
| Jun 30, 2025 | 22.06 Mn |
| Mar 31, 2025 | 16.74 Mn |
| Dec 31, 2024 | 13.43 Mn |
| Sep 30, 2024 | 17.35 Mn |
| Jun 30, 2024 | 20.22 Mn |
| Mar 31, 2024 | 19.90 Mn |
| Dec 31, 2023 | 11.41 Mn |
| Sep 30, 2023 | 13.67 Mn |
| Jun 30, 2023 | 10.02 Mn |
| Mar 31, 2023 | 10.93 Mn |
| Dec 31, 2022 | 9.02 Mn |
| Sep 30, 2022 | 8.45 Mn |
| Jun 30, 2022 | 9.45 Mn |
| Mar 31, 2022 | 9.07 Mn |
| Dec 31, 2021 | 7.97 Mn |
| Sep 30, 2021 | 5.64 Mn |
| Jun 30, 2021 | 4.79 Mn |